At The Care Pharmacy, our UK pharmacists provide clear guidance, safe treatment pathways, and personalised support for people considering GLP-1 options
GLP-1 receptor agonists
2035 Mapping Treatment-Induced Adverse Events against HRQoL Questionnaires in Non-Small Cell Lung Cancer: Evaluation of the EORTC QLQ-C30 and QLQ-LC29 Lotte Van der Weijst 1 , Cecilia Pompili 2,3 , Maria Teixeira 4 , Hayat Hamzeh 5 , Claire Piccinin 4 , Madeline Pe 4 1 EORTC, Brussels, Belgium, 2 Institute for Clinical & Applied Health Research, University of Hull, UK, 3 Section of Patient Centred Outcomes Research, University of Leeds, UK, 4 Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 5 Leeds Institute of Medical Research, University of Leeds, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2035 Aims This study aims to evaluate the relevance of health-related quality of life (HRQoL) questionnaires in capturing treatment-induced adverse events
Its warm-up timehow long until a glucose reading is available after the CGM is insertedis two hours
Natural GLP-1 lasts only a minute or two before an enzyme inactivates it, so most of its signal stays near the gut
Claims we make: improves the appearance of fine lines, firmer-looking skin, prescription-strength 3%